Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueDepreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuances
Ratios

AdaptHealth (AHCO) Shares Outstanding (2017 - 2026)

AdaptHealth has reported Shares Outstanding over the past 9 years, most recently at $135.5 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 0.63% year-over-year to $135.5 million; the TTM value through Dec 2025 reached $135.5 million, up 0.63%, while the annual FY2025 figure was $135.5 million, 0.63% up from the prior year.
  • Shares Outstanding for Q4 2025 was $135.5 million at AdaptHealth, roughly flat from $135.4 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $135.5 million in Q4 2025 and troughed at $124000.0 in Q3 2021.
  • A 5-year average of $127.2 million and a median of $134.4 million in 2022 define the central range for Shares Outstanding.
  • On a YoY basis, Shares Outstanding climbed as much as 108547.58% in 2022 and fell as far as 99.9% in 2022.
  • Year by year, Shares Outstanding stood at $133.8 million in 2021, then increased by 0.44% to $134.4 million in 2022, then dropped by 1.34% to $132.6 million in 2023, then grew by 1.48% to $134.6 million in 2024, then rose by 0.63% to $135.5 million in 2025.
  • Business Quant data shows Shares Outstanding for AHCO at $135.5 million in Q4 2025, $135.4 million in Q3 2025, and $135.2 million in Q2 2025.